Sanofi Casting Blame For Failed EpiPen Rival, Mylan Says
Mylan urged a Kansas federal judge Friday to nix Sanofi's antitrust allegations in a broader multidistrict litigation, arguing that its EpiPen competed with Sanofi's epinephrine auto-injector fair and square, only for...To view the full article, register now.
Already a subscriber? Click here to view full article